Latest Regulatory Compliance News

Brazilian Critical Minerals reports exceptional pilot field trial results at its Ema rare earth project, advancing permitting and feasibility studies while attracting strong market interest.

Lodestar Minerals has issued a replacement proxy form to correct an omission in its original Notice of Meeting, ensuring shareholders can fully participate in the upcoming General Meeting.

Surefire Resources NL has responded to ASX inquiries concerning multiple breaches of its Securities Trading Policy by Executive Chairman Vladimir Nikolaenko, committing to enhanced compliance measures and policy revisions.

Multistack International Limited reported a net cash outflow for the quarter ending June 2025 but has strengthened its balance sheet through major loan repayments and is progressing acquisition discussions with SuperLink.

Sky Metals reports a highly successful drilling campaign at its Tallebung Tin Project, revealing significant new high-grade tin zones and expanding the deposit footprint. The company advances metallurgical testing and environmental studies to support upcoming mining approvals.

Askari Metals supplements its Nejo Gold Project acquisition announcement with detailed drill hole data and confirms the reliability of historical exploration results, while noting compliance limitations.

Mithril Silver and Gold Limited has successfully closed a C$11.5 million brokered private placement, positioning the company to advance its Copalquin district project in Mexico while bolstering working capital.

Singular Health has landed a pivotal $2 million US pilot contract with Provider Network Solutions and completed an $8 million capital raise, advancing its medical imaging platform’s regulatory and product development milestones.

Pursuit Minerals has issued over 8.5 million placement options and additional shares to directors following shareholder approval, setting the stage for potential capital inflows through option exercises by mid-2027.

Black Rock Mining Limited has launched a prospectus offering over 108 million unquoted options to participants of a recent $5 million placement, aiming to support the development of its Mahenge Graphite Project in Tanzania.

DY6 Metals has clarified its compliance with ASX continuous disclosure rules following a material capital raising and CEO appointment, confirming timely and confidential handling of sensitive information.

Zelira Therapeutics has locked in a $650,000 loan facility secured against its anticipated FY25 R&D tax rebate, aiming to accelerate its HOPE SPV clinical trial and strengthen working capital.